Stock Price Quote

CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE429.10-3.6 (-0.83 %)
PREV CLOSE ( ) 432.70
OPEN PRICE ( ) 436.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 134119
TODAY'S LOW / HIGH ( )426.00 436.00
52 WK LOW / HIGH ( )212.7 451.15
NSE429.10-3.75 (-0.87 %)
PREV CLOSE( ) 432.85
OPEN PRICE ( ) 432.00
BID PRICE (QTY) 429.10 (31)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3001559
TODAY'S LOW / HIGH( ) 425.50 434.20
52 WK LOW / HIGH ( )202 464
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX

NEWS

12Nov Zydus Cadila successfully completes ph
Zydus Cadila has successfully completed a Phase 2 clinical trial in COVI..
12Nov Cadila Healthcare informs about press
Cadila Healthcare has informed that it has enclosed a copy of press rele..
12Nov Zydus Cadila surges on the BSE
Cadila Healthcare is currently trading at Rs. 429.75, up by 13.60 points..
03Nov Cadila Healthcare informs about press
Cadila Healthcare has informed that it has enclosed a copy of press rele..
03Nov Zydus files IND application of ZYIL1
Zydus has filed the IND application of ZYIL1, a novel oral small molecul..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit473014129
Gross Profit 5614 15577
Operating Profit 688422725
Net Sales 2056963474

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Valiant Organics (BSE)
peergroup  3174.15 (4.10%)
M.Cap ( in Cr)4309.46
Procter&Gamble Healt (BSE)
peergroup  6339.50 (1.79%)
M.Cap ( in Cr)10523.18
Abbott India (BSE)
peergroup  15305.70 (0.71%)
M.Cap ( in Cr)32523.54
Sanofi India (BSE)
peergroup  8326.50 (1.16%)
M.Cap ( in Cr)19176.45
Dr. Reddys Lab (BSE)
peergroup  4910.95 (1.71%)
M.Cap ( in Cr)81661.73

Shareholding Pattern

NON-INSTITUTION 8.05%
PROMOTERS 74.88%
MUTUAL FUNDS/UTI 7.27%
FI/BANKS/INSURANCE 5.07%
GOVERNMENT 0.19%
FII 0%

About Cadila Healthcare Ltd.

Cadila Healthcare Ltd. was incorporated in the year 1995. Its today's share price is 432.7. Its current market capitalisation stands at Rs 43928.79 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Apurva S Diwanji, Dharmishta N Raval, Nitin R Desai, Bhadresh K Shah, Mukesh M Patel, Ganesh N Nayak, Sharvil P Patel, Pankaj R Patel.

It is listed on the BSE with a BSE Code of 532321 , NSE with an NSE Symbol of CADILAHC and ISIN of INE010B01027. It's Registered office is at Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar HighwayAhmedabad-382481, Gujarat. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Mukesh M Shah & Co, RR Patel & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)